ChemicalBook >>Brompheniramine>>3-(4-Bromophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine(86-22-6)

3-(4-Bromophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine(86-22-6)

3-(4-Bromophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine(86-22-6)
Product IdentificationBack to Contents
【Product Name】

3-(4-Bromophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine
【Synonyms】

1-(p-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane
2-Bromopheniramine
2-Pyridinepropanamine, g-(4-bromophenyl)-N,N-dimethyl-
3-(4-Bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
3-(p-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine
Parabromodylamine
【CAS】

86-22-6
【Formula】

C16H19BrN2
【Molecular Weight】

319.24
【EINECS】

201-657-8
【Merck】

12,1467
【Beilstein/Gmelin】

217066
【Beilstein Reference】

5-22-10-00490
Physical and Chemical PropertiesBack to Contents
【Appearance】

Oily liquid with slightly yellow color. Characteristic amine-like.
【Solubility in water】

Insoluble
【Boiling Point】

147 - 152 (0.5 torr)
【pKa/pKb】

4.67 (pKb)
【Usage】

Medication.
First Aid MeasuresBack to Contents
【Ingestion】

Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
【Inhalation】

If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
【Skin】

Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes.
【Eyes】

Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.
Handling and StorageBack to Contents
【Storage】

Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
【Handling】

All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Hazards IdentificationBack to Contents
【Inhalation】

Pneumonitis, chest tightness, and wheezing have been reported.
【Skin】

Skin may be flushed, warm and dry after overdose.
【Eyes】

Anticholinergic effects, such as prolonged dialation of the pupils, nasal dryness and stuffiness, and mouth and throat dryness, can occur with overdose or therapeutic use.
【Ingestion】

Overdose may cause anticholinergic effects of ileus and diminished bowel sounds. Nausea, vomiting, and loss of appetite may occur .
Exposure Controls/Personal ProtectionBack to Contents
【Personal Protection】

Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
【Respirators】

Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
【Exposure Effects】

Rapid heart rate is common. Elevated body temperature, abnormally low blood pressure, and elevated blood pressure have been reported. overdose may result in either CNS depression, including coma, or CNS stimulation, such as toxic psychosis. Subsequent seizures are not uncommon, especially in children. A higher incidence of seizures has been reported following pheniramine overdoses. Therapeutic use has been associated with acute dystonic reactions and dyskinesias. In general, there have been few reported teratogenic effects in humans, although animal studies have suggested that certain antihistamines have teratogenic potential. <br>Pyloric stenosis has occurred in infants following maternal use of antihistamines. <br>Small amounts of antihistamines are excreted in breast milk.
Fire Fighting MeasuresBack to Contents
【Fire Fighting】

Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Accidental Release MeasuresBack to Contents
【Small spills/leaks】

Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Stability and ReactivityBack to Contents
【Stability】

Sensitive to light maleate.
【Incompatibilities】

Strong oxidizing agents.
Company Name: Shanghai TaoSu Biochemical Technology Co., Ltd.
Tel: 021-33632979
Fax: 021-34692979
WebSite: www.tsbiochem.com
Company Name: UHN Shanghai Research & Development Co., Ltd.
Tel: 021-58958002 18930822973
Fax: 021-58958618
WebSite: http://www.uhnshanghai.com
Company Name: Chengdu Saint - Kay Biotechnology Co., Ltd.
Tel: 028-85157043 15882256948
Fax:
WebSite: https://www.chemicalbook.com/ShowSupplierProductsList30701/0.htm
Company Name: Dayang Chem (Hangzhou) Co.,Ltd.
Tel: 571-88938639 +8617705817739
Fax: +86-571-88938652,+86-571- 88492614
WebSite: www.dycnchem.com
Company Name: AFINE CHEMICALS LIMITED
Tel: 0571-85134551
Fax: 008657185134895
WebSite: www.afinechem.com/index.html
Company Name: Shaanxi Dideu Medichem Co. Ltd
Tel: +86-029-89586680 +86-18192503167
Fax: +86-29-88380327
WebSite: www.dideu.com
Company Name: SIMAGCHEM CORP
Tel: +86-13806087780
Fax:
WebSite: http://www.simagchem.com/
Company Name: Hubei Jusheng Technology Co.,Ltd.
Tel: 18871490254
Fax: 027-59599243
WebSite: www.hubeijusheng.com